Table 2.
Baseline characteristic of patients
| Characteristic | n=25 |
|---|---|
| Median age, years (range) | 62 (40,75) |
| Sex, n (%) | |
| Male | 19 (76) |
| Female | 6 (24) |
| ECOG PS score, n (%) | |
| 0 | 19 (76) |
| 1 | 6 (24) |
| Tumor location, n (%) | |
| Head/uncinate | 13 (52) |
| Neck | 4 (16) |
| Body/tail | 8 (32) |
| Tumor type, n (%) | |
| BRPC | 10 (40) |
| LAPC | 15 (60) |
| Baseline CA19-9, n (%) | |
| ≤27 U/mL, normal | 6 (24) |
| ≥27 U/mL, elevated | 19 (76) |
| Vascular involvement, n (%) | |
| Arterial alone | 6 (24) |
| Venous alone | 10 (40) |
| Arterial + venous | 9 (36) |
ECOG PS, Eastern Cooperative Oncology Group Performance Status; BRPC, Borderline Resectable Pancreatic Cancer; LAPC, Locally Advanced Pancreatic Cancer; CA19-9, Carbohydrate Antigen 19-9.